Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CICLESONIDE Cause Therapeutic response decreased? 53 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 53 reports of Therapeutic response decreased have been filed in association with CICLESONIDE (Alvesco). This represents 0.9% of all adverse event reports for CICLESONIDE.

53
Reports of Therapeutic response decreased with CICLESONIDE
0.9%
of all CICLESONIDE reports
0
Deaths
42
Hospitalizations

How Dangerous Is Therapeutic response decreased From CICLESONIDE?

Of the 53 reports, 42 (79.2%) required hospitalization.

Is Therapeutic response decreased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CICLESONIDE. However, 53 reports have been filed with the FAERS database.

What Other Side Effects Does CICLESONIDE Cause?

Asthma (4,026) Dyspnoea (2,953) Wheezing (2,785) Therapeutic product effect incomplete (2,337) Loss of personal independence in daily activities (1,575) Obstructive airways disorder (1,403) Cough (1,395) Sleep disorder due to a general medical condition (1,333) Full blood count abnormal (916) Productive cough (847)

What Other Drugs Cause Therapeutic response decreased?

DUPILUMAB (7,824) ETANERCEPT (3,460) ONABOTULINUMTOXINA (2,685) METHOTREXATE (2,668) INFLIXIMAB (1,991) RITUXIMAB (1,728) LEFLUNOMIDE (1,574) TOCILIZUMAB (1,512) HYDROXYCHLOROQUINE (1,485) ADALIMUMAB (1,357)

Which CICLESONIDE Alternatives Have Lower Therapeutic response decreased Risk?

CICLESONIDE vs CICLOPIROX CICLESONIDE vs CICLOPIROX OLAMINE CICLESONIDE vs CICLOSPORIN CICLESONIDE vs CIDOFOVIR CICLESONIDE vs CILASTATIN

Related Pages

CICLESONIDE Full Profile All Therapeutic response decreased Reports All Drugs Causing Therapeutic response decreased CICLESONIDE Demographics